Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VENETOCLAX Cause Diffuse large b-cell lymphoma refractory? 25 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Diffuse large b-cell lymphoma refractory have been filed in association with VENETOCLAX (Venclexta). This represents 0.1% of all adverse event reports for VENETOCLAX.

25
Reports of Diffuse large b-cell lymphoma refractory with VENETOCLAX
0.1%
of all VENETOCLAX reports
4
Deaths
1
Hospitalizations

How Dangerous Is Diffuse large b-cell lymphoma refractory From VENETOCLAX?

Of the 25 reports, 4 (16.0%) resulted in death, 1 (4.0%) required hospitalization, and 2 (8.0%) were considered life-threatening.

Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VENETOCLAX. However, 25 reports have been filed with the FAERS database.

What Other Side Effects Does VENETOCLAX Cause?

Death (9,412) Off label use (6,252) Neutropenia (3,041) Febrile neutropenia (2,663) Platelet count decreased (2,367) Pyrexia (2,351) Pneumonia (2,300) Fatigue (2,281) Diarrhoea (2,082) White blood cell count decreased (1,913)

What Other Drugs Cause Diffuse large b-cell lymphoma refractory?

RITUXIMAB (461) CYCLOPHOSPHAMIDE (360) DOXORUBICIN (345) VINCRISTINE (331) ETOPOSIDE (244) PREDNISONE (214) EPCORITAMAB-BYSP (198) CYTARABINE (193) DEXAMETHASONE (170) CISPLATIN (156)

Which VENETOCLAX Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?

VENETOCLAX vs VENLAFAXINE VENETOCLAX vs VENTAVIS VENETOCLAX vs VENTOLIN VENETOCLAX vs VENTOLIN HFA VENETOCLAX vs VERAPAMIL

Related Pages

VENETOCLAX Full Profile All Diffuse large b-cell lymphoma refractory Reports All Drugs Causing Diffuse large b-cell lymphoma refractory VENETOCLAX Demographics